В. С. Гуревич

2.2k total citations
71 papers, 477 citations indexed

About

В. С. Гуревич is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, В. С. Гуревич has authored 71 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 10 papers in Cardiology and Cardiovascular Medicine and 7 papers in Epidemiology. Recurrent topics in В. С. Гуревич's work include Lipoproteins and Cardiovascular Health (18 papers), Aldose Reductase and Taurine (7 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). В. С. Гуревич is often cited by papers focused on Lipoproteins and Cardiovascular Health (18 papers), Aldose Reductase and Taurine (7 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). В. С. Гуревич collaborates with scholars based in Russia, United States and United Kingdom. В. С. Гуревич's co-authors include Jacob Bornstein, Pier Luigi Meroni, I. Haviv, Ravid Straussman, Inbar Ben‐Shachar, Omry Koren, Yehuda Shoenfeld, Boris Fichtman, Nancy Gavert and Simcha Yagel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the New York Academy of Sciences and The Journal of the Acoustical Society of America.

In The Last Decade

В. С. Гуревич

61 papers receiving 455 citations

Peers

Countries citing papers authored by В. С. Гуревич

Since Specialization

Citations

This map shows the geographic impact of В. С. Гуревич's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by В. С. Гуревич with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites В. С. Гуревич more than expected).

Fields of papers citing papers by В. С. Гуревич

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by В. С. Гуревич. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by В. С. Гуревич. The network helps show where В. С. Гуревич may publish in the future.

Co-authorship network of co-authors of В. С. Гуревич

This figure shows the co-authorship network connecting the top 25 collaborators of В. С. Гуревич. A scholar is included among the top collaborators of В. С. Гуревич based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with В. С. Гуревич. В. С. Гуревич is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Artificial intelligence in medicine: history, current status and future directions of research 2025 ·Angiology and vascular surgery ·А. В. Светликов, (unknown), В. С. Гуревич, (unknown), (unknown), (unknown), (unknown), P. K. Yаblonskiy	0
2	Review of the European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms: what is new and prospects for development 2024 ·Angiology and vascular surgery ·А. В. Светликов, (unknown), (unknown), В. С. Гуревич, (unknown)	0
3	Impact of COVID-19 on pro- and antiatherogenic lipoproteins (cross-sectional population study) 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), В. С. Гуревич	0
4	Cardiovascular effects of omega-3 polyunsaturated fatty acids: position of omega-3 polyunsaturated fatty acids in Russian and international guidelines. Council of Experts 2023 ·Kardiologiia ·Yu. V. Mareev, М. В. Ежов, S. V. Villevalde, А. С. Алиева, А. Г. Обрезан, А. В. Тарасов, A. V. Panov, В. О. Константинов, И. В. Сергиенко, (unknown), М. М. Батюшин, В. С. Гуревич, E. I. Tarlovskaya, Н. А. Козиолова, О. А. Громова, Yа. A. Orlova, G. P. Arutyunov, Mareev VIu	2
5	Age and gender peculiarities of the lipid spectrum in the urban population before and during the COVID 19 epidemic 2023 ·Atherosclerosis ·В. С. Гуревич, (unknown), (unknown)	1
6	Surgical tactics of treatment for chronic ischemia in patients with atherosclerotic lesions of the deep femoral artery and occlusion of the superficial femoral artery 2023 ·Angiology and vascular surgery ·А. В. Светликов, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), В. С. Гуревич	1
7	Дислипидемия 2022 – как снизить риск и достичь цели? 2022 ·(unknown), И. В. Сергиенко, Н. М. Ахмеджанов, В. С. Гуревич, (unknown)	0
8	Нерешенные проблемы дислипидемии и резидуального сердечно-сосудистого риска 2022 ·В. С. Гуревич, (unknown), (unknown), И. В. Сергиенко, А. С. Алиева, (unknown), (unknown), (unknown), (unknown), (unknown), В. О. Константинов	5
9	Control of dyslipidemia in the prevention of recurrent ischemic cerebrovascular accidents (expert opinion) 2022 ·SHILAP Revista de lepidopterología ·M. М. Tanashyan, N. А. Shamalov, (unknown), (unknown), (unknown), Д. Р. Хасанова, (unknown), В. А. Парфенов, (unknown), (unknown), В. С. Гуревич, (unknown)	1
10	Inclisiran – a new era in lipid-lowering therapy 2022 ·Kardiologiia ·М. И. Воевода, В. С. Гуревич, М. В. Ежов, И. В. Сергиенко	1
11	Organization of lipid centers operation in the Russian Federation — new opportunities 2021 ·SHILAP Revista de lepidopterología ·М. В. Ежов, О. Л. Барбараш, М. И. Воевода, В. С. Гуревич, Н. Н. Везикова, (unknown), И. В. Сергиенко, В. В. Кашталап, А. Н. Мешков, D. V. Duplyakov, (unknown), S. А. Boytsov	5
12	Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council 2021 ·SHILAP Revista de lepidopterología ·М. В. Ежов, В. В. Кухарчук, И. В. Сергиенко, Н. М. Ахмеджанов, М. И. Воевода, В. С. Гуревич, В. В. Кашталап, (unknown), (unknown), И. И. Шапошник	2
13	Identification of novel variants in the LDLR gene in Russian patients with familial hypercholesterolemia using targeted sequencing 2020 ·Biomedical Reports ·(unknown), (unknown), О.Н. Иванова, (unknown), (unknown), Yury A. Barbitoff, (unknown), (unknown), В. С. Гуревич, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sofya Pchelina, Аndrey S. Glotov, Ekaterina Zakharova, Oleg S. Glotov	14
14	DIAGNOSIS AND TREATMENT OF FAMILY HYPERCHOLESTEROLEMIA (russian guidelines) 2017 ·The Bulletin of Contemporary Clinical Medicine ·М. В. Ежов, И. В. Сергиенко, (unknown), В. В. Кухарчук, (unknown), А. Н. Мешков, А. И. Ершова, В. С. Гуревич, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), М. И. Воевода, И. И. Шапошник	4
15	Autoimmune Nature of Influenza Atherogenicity 2005 ·Annals of the New York Academy of Sciences ·В. С. Гуревич, (unknown), (unknown)	18
16	Statins and autoimmune diseases 2004 ·Autoimmunity Reviews ·В. С. Гуревич, Ora Shovman, (unknown), Pier Luigi Meroni, Yehuda Shoenfeld	28
17	Influenza, autoimmunity and atherogenesis 2004 ·Autoimmunity Reviews ·В. С. Гуревич	26
18	Antithrombotic and Vasorelaxant Properties of a Novel Synthetic RGD Peptide Containing Nitric Oxide 1997 ·Pharmacology ·В. С. Гуревич, David Lominadze, Ayotunde S.O. Adeagbo, S. V. Burov, (unknown), (unknown), Frederick N. Miller, Dale A. Schuschke	4
19	Efficiency of holographic recording by pulsed laser radiation with various spectral and temporal parameters 1995 ·Optics and Spectroscopy ·(unknown), (unknown), В. С. Гуревич, Mikhail E. Gusev	1
20	Antioxidative activity of high density lipoproteins in vivo 1993 ·Atherosclerosis ·(unknown), В. С. Гуревич, (unknown), (unknown), (unknown), (unknown), (unknown)	108

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact